Optegra opens first London eye hospital

Article

Optegra announced the launch of its first eye Hospital in London this week.

Optegra announced the launch of its first eye Hospital in London this week.

The firm's sixth hospital consists of three consulting rooms, six diagnostic rooms, a treatment room and two operating theatres. It is equipped with high technology diagnostic and surgical equipment.

Optegra has hospitals located in Birmingham, Solent, Surrey, Yorkshire and Manchester. The company also runs several outreach clinics through partnerships with GPs and other ophthalmic professionals.

Managing Director of Optergra, Gareth Steer, commented, "Optegra’s vision is to become the most trusted provider of ophthalmology services, by working together with leading consultant ophthalmologists and providing the best facilities and highly trained staff, to deliver the best clinical outcomes and exceptional patient experience. We are pleased to announce the launch of our new hospital in London and we are delighted to bring the five star patient care, so closely associated with Optegra, to an even wider group of patients."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.